secwatch.observer — SEC 8-K summary
======================================

Issuer:     FENNEC PHARMACEUTICALS INC. (FENC)
CIK:        0001211583
Form:       8-K
Filed at:   2025-11-17T23:59:59+00:00
Accession:  0001104659-25-112912
Event type: other_material
Sentiment:  neutral
Materiality: 0.65
Item codes: 1.01, 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Fennec prices $35M public offering of 4.7M shares at $7.50/share to repay debt
------------------------------------------------------------------------------

- Offering of 4,666,667 common shares at $7.50 per share; gross proceeds ~$35M.
- Underwriters granted 30-day option to purchase up to 700,000 additional shares.
- Net proceeds to repurchase and redeem certain indebtedness and for working capital.
- Closing expected November 17, 2025, subject to customary conditions.
- Joint book-running managers: Piper Sandler & Co. and Craig-Hallum Capital Group.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1211583/000110465925112912/0001104659-25-112912-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1211583/000110465925112912/tm2531308d1_8k.htm
  HTML page:      https://secwatch.observer/filing/0001104659-25-112912

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer